These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 9143600)
21. Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays. de Mendoza C; Lu W; Machuca A; Sainz M; Castilla J; Soriano V J Med Virol; 2001 Jul; 64(3):217-22. PubMed ID: 11424107 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda. Spacek LA; Lutwama F; Shihab HM; Summerton J; Kamya MR; Ronald A; Laeyendecker O; Quinn TC; Mayanja-Kizza H Int J STD AIDS; 2011 Jun; 22(6):310-4. PubMed ID: 21680665 [TBL] [Abstract][Full Text] [Related]
23. Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic hiv infection during structured treatment interruptions. Prado JG; Shintani A; Bofill M; Clotet B; Ruiz L; Martinez-Picado J J Clin Microbiol; 2004 Apr; 42(4):1620-5. PubMed ID: 15071015 [TBL] [Abstract][Full Text] [Related]
24. A comparison of immunocomplex-dissociated serum HIV-1 p24 antigenemia and plasma HIV-1 viral load: assessment of 3,129 paired assays. Manfredi R; Borderi M; Re MC; Furlini G; Monari P; Spinosa Guzmán SM; Tadolini M; Talò S; Donzelli C; Maldini C; Chiodo F New Microbiol; 1999 Jul; 22(3):269-75. PubMed ID: 10423746 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of HIV-1 p24 antigenemia and level of CD8+CD38+ T cells as surrogate markers of HIV-1 RNA viral load in HIV-1-infected patients in Dakar, Senegal. Ondoa P; Dieye TN; Vereecken C; Camara M; Diallo AA; Fransen K; Litzroth A; Mboup S; Kestens L J Acquir Immune Defic Syndr; 2006 Apr; 41(4):416-24. PubMed ID: 16652048 [TBL] [Abstract][Full Text] [Related]
26. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients]. Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648 [TBL] [Abstract][Full Text] [Related]
27. HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss. Schüpbach J; Günthard H; Joos B; Fischer M; Böni J; Tomasik Z; Yerly S; Perrin L; Battegay M; Furrer H; Vernazza P; Bernasconi E; Hirschel B; J Acquir Immune Defic Syndr; 2005 Nov; 40(3):250-6. PubMed ID: 16249697 [TBL] [Abstract][Full Text] [Related]
28. Comparison of an amplified enzyme-linked immunosorbent assay with procedures based on molecular biology for assessing human immunodeficiency virus type 1 viral load. Goldschmidt PL; Devillechabrolle A; Ait-Arkoub Z; Aubin JT Clin Diagn Lab Immunol; 1998 Jul; 5(4):513-8. PubMed ID: 9665959 [TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. Cao Y; Ho DD; Todd J; Kokka R; Urdea M; Lifson JD; Piatak M; Chen S; Hahn BH; Saag MS AIDS Res Hum Retroviruses; 1995 Mar; 11(3):353-61. PubMed ID: 7786581 [TBL] [Abstract][Full Text] [Related]
30. Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay. Jennings C; Fiscus SA; Crowe SM; Danilovic AD; Morack RJ; Scianna S; Cachafeiro A; Brambilla DJ; Schupbach J; Stevens W; Respess R; Varnier OE; Corrigan GE; Gronowitz JS; Ussery MA; Bremer JW J Clin Microbiol; 2005 Dec; 43(12):5950-6. PubMed ID: 16333081 [TBL] [Abstract][Full Text] [Related]
31. Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. Weber B; Gürtler L; Thorstensson R; Michl U; Mühlbacher A; Bürgisser P; Villaescusa R; Eiras A; Gabriel C; Stekel H; Tanprasert S; Oota S; Silvestre MJ; Marques C; Ladeira M; Rabenau H; Berger A; Schmitt U; Melchior W J Clin Microbiol; 2002 Jun; 40(6):1938-46. PubMed ID: 12037046 [TBL] [Abstract][Full Text] [Related]
32. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. Piatak M; Saag MS; Yang LC; Clark SJ; Kappes JC; Luk KC; Hahn BH; Shaw GM; Lifson JD AIDS; 1993 Nov; 7 Suppl 2():S65-71. PubMed ID: 7909227 [TBL] [Abstract][Full Text] [Related]
33. Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings? Gupta S; Palchaudhuri R; Neogi U; Srinivasa H; Ashorn P; De Costa A; Källander C; Shet A BMJ Open; 2016 Jan; 6(1):e008795. PubMed ID: 26817634 [TBL] [Abstract][Full Text] [Related]
34. Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay. Pascual A; Cachafeiro A; Funk ML; Fiscus SA J Clin Microbiol; 2002 Jul; 40(7):2472-5. PubMed ID: 12089264 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of p24-based antiretroviral treatment monitoring in pediatric HIV-1 infection: prediction of the CD4+ T-cell changes between consecutive visits. Brinkhof MW; Böni J; Steiner F; Tomasik Z; Nadal D; Schüpbach J J Acquir Immune Defic Syndr; 2006 Apr; 41(5):557-62. PubMed ID: 16652029 [TBL] [Abstract][Full Text] [Related]
36. Earlier detection of human immunodeficiency virus type 1 p24 antigen and immunoglobulin G and M antibodies to p17 antigen in seroconversion serum panels by immune complex transfer enzyme immunoassays. Hashida S; Ishikawa S; Hashinaka K; Nishikata I; Oka S; Ishikawa E Clin Diagn Lab Immunol; 2000 Nov; 7(6):872-81. PubMed ID: 11063490 [TBL] [Abstract][Full Text] [Related]
37. Comparison of HIV type 1 RNA plasma viremia, p24 antigenemia, and unintegrated DNA as viral load markers in pediatric patients. Bush CE; Donovan RM; Manzor O; Baxa D; Moore E; Cohen F; Saravolatz LD AIDS Res Hum Retroviruses; 1996 Jan; 12(1):11-5. PubMed ID: 8825613 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of three different commercial procedures for quantifying human immunodeficiency virus type-1 RNA levels. Aschbacher R; Monari P; Lolli S; Donzelli C; Colangeli V; Vignoli M; Ramazzotti E; Furlini G; Re MC New Microbiol; 1999 Jan; 22(1):1-9. PubMed ID: 10190111 [TBL] [Abstract][Full Text] [Related]
39. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test. Vandamme AM; Schmit JC; Van Dooren S; Van Laethem K; Gobbers E; Kok W; Goubau P; Witvrouw M; Peetermans W; De Clercq E; Desmyter J J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Oct; 13(2):127-39. PubMed ID: 8862277 [TBL] [Abstract][Full Text] [Related]
40. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients. Schapiro JM; Winters MA; Stewart F; Efron B; Norris J; Kozal MJ; Merigan TC Ann Intern Med; 1996 Jun; 124(12):1039-50. PubMed ID: 8633817 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]